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[11C]Flumazenil-PETA third of patients with intractable temporal lobe epilepsy and hippocampal sclerosis (HS) are not seizure free
(NSF) after surgery. Increased periventricular [11C]ﬂumazenil (FMZ) binding, reﬂecting heterotopic neuron
concentration, has been described as one predictor of NSF outcome at the group level. We aimed to replicate this
ﬁnding in an independent larger cohort and investigated whether NSF outcome can be predicted in individuals.
Preoperative [11C]FMZ summed radioactivity imageswere available for 16 patientswithHS and 41 controls. Images
were analyzed using SPM8, explicitly including the white matter, and correction for global radioactivity via group-
speciﬁc ANCOVA. Periventricular increases were assessed with a mask and different cutoffs for distinguishing NSF
and seizure free (SF) patients.
NSF patients had increased [11C]FMZ binding around the posterior horn of the ventricles ipsilaterally (z = 2.53)
and contralaterally (z = 4.44) to the seizure focus compared with SF patients. Compared with controls, SF pa-
tients had fewer periventricular increases (two clusters, total volume 0.87 cm3, zmax = 3.8) than NSF patients
(two ipsilateral and three contralateral clusters, 6.15 cm3, zmax = 4.8). In individuals and at optimized cutoffs,
ﬁve (63%) of eight NSF patients and one (13%) of eight SF patients showed periventricular increases compared
with controls (accuracy 75%). Only one (2%) of the 41 controls had increases at the same cutoff.
The association between periventricular [11C]FMZ increases and NSF outcome after temporal lobe resection for
HShas been conﬁrmed in an independent cohort on simple summed activity images. [11C]FMZ-PETmay be useful
for individual preoperative counseling with clinically relevant accuracy.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license. 1. Introduction
Surgical resection of the epileptogenic region is an effective therapy
for individualswithmedically refractory temporal lobe epilepsy, leading
to seizure freedom in about two thirds of patients (Foldvary et al., 2000;
Spencer and Huh, 2008; Sperling et al., 1996; Wiebe et al., 2001).
However, thismeans that around a third of patientswith epilepsy and
hippocampal sclerosis (HS) undergoing surgery ails to become seizure
free. Identiﬁcation of reliable predictors of suboptimal outcome would
be useful for patient management and counseling.ERMEP-Imagerie du vivant, 59
34.
dis.org (A. Hammers).
c. Open access under CC BY-NC-ND licePatients with discrete abnormalities (i.e. lesions or HS) on preoper-
ative MRI have a signiﬁcantly higher probability of seizure freedom
than patients without obvious abnormality (McIntosh et al., 2004). A
seizure free outcome is also more likely if the focal lesions visible on
MRI are concordant with interictal and ictal EEG and electrocorticogra-
phy patterns (Yang et al., 2011). Typical patterns of HS include damage
in particular to the hippocampal subﬁelds (Lorente de Nó, 1934) CA1
and CA3 (Sommer, 1880) or all subﬁelds (Blumcke et al., 2007).
There is evidence to suggest that atypical histological HS patterns,
e.g. damage restricted to the hilar region, may be predictive of poorer
outcome (Blumcke et al., 2007; de Lanerolle et al., 2003; Sagar and
Oxbury, 1987), including when HS patterns are analyzed quantitatively
(Thom et al., 2010).
Other potential biomarkers to predict postoperative NSF outcome
postoperatively include higher age at surgery and longer duration of
the epilepsy and indicators of early spread of seizures, i.e. presence of
hand dystonic posturing and presence of secondarily generalizednse. 
243J. Yankam Njiwa et al. / NeuroImage: Clinical 3 (2013) 242–248tonic–clonic seizures. Models constructed based on these variables
were at best able to predict seizure status after 24 months with 73%
accuracy in a series of 135 patients (Aull-Watschinger et al., 2008).
In addition, ﬁndings on predictors of NSF outcome are inconsistent
(Aull-Watschinger et al., 2008; Hardy et al., 2003; Janszky et al., 2005).
[11C]Flumazenil (FMZ) binds to the benzodiazepine sites of GABAA
receptors. Cortical decreases of [11C]FMZ binding are associated with
epileptogenic foci (Hammers, 2004; Juhász, 2012).
In a series of papers examining white matter (WM) [11C]FMZ
volume-of-distribution (VT) by voxel-based analysis (statistical para-
metric mapping, SPM), we have shown the following: 1) WM [11C]
FMZ VT correlated strongly with the histologically determined number
of heterotopic neurons in the WM (Hammers et al., 2001, 2002), 2)
WM [11C]FMZVTwas increased in the temporal lobe in 11/18 individual
patients with TLE and normal MRI (Hammers et al., 2002), 3)WM [11C]
FMZ VT was increased in periventricular regions in 7/44 patients with
extratemporal epilepsy (Hammers et al., 2003b), and 4) periventricular
[11C]FMZ VT increases detected by PET in MRI-negative patients
appeared identically to such increases due toMRI visible periventricular
heterotopia (Hammers et al., 2003b).
Finally, at the group level, increasedpreoperative periventricularWM
[11C]FMZ VTwas associated with a postoperative outcome of incomplete
seizure freedom after temporal lobe resection for HS (Hammers et al.,
2005).
The present study ﬁrst replicates this association in a new indepen-
dent cohort of patients with pathologically provenHS, and then extends
the work to enable reﬁnement of the post-operative prognosis for indi-
vidual patients, based on their preoperative [11C]FMZ-PET. Instead of
[11C]FMZ-VT images, methodologically less demanding summed radio-
activity images were used in this study.
2. Material and methods
2.1. Participants
We retrospectively identiﬁed all patients fulﬁlling the following
criteria:
1) Suffering from mesial TLE,
2) HS diagnosed on MRI (conﬁrmed by histopathology for most of the
patients),
3) Temporal lobe surgery with a postsurgical follow-up for at least
twelve months,
4) Availability of preoperative [11C]FMZ PET on the Siemens/CTI
HR + PET camera installed at the CERMEP imaging center.
Some of these patients (patients #2, #4, #7, #10, #12, #15, #16)
have already been investigated for other questions in other studies
(Bouvard et al., 2005; Ryvlin et al., 1998).
The presurgical investigation of candidates for surgery included
obtaining each patient's medical history, physical examination, long-
term video electroencephalography (VEEG), and, if required, stereotax-
ic EEG (SEEG). Sixteen patients (four men and twelve women) fulﬁlled
the criteria. Nine had left-sided HS and six right-sided HS, diagnosed on
MRI by experienced radiologists and neurologists. All patients had stan-
dard anterior temporal lobectomies by the same neurosurgeon; in pa-
tient #10, SEEG had shown some seizures to originate in the inferior
insula, and she underwent an additional inferior insulectomy (Malak
et al., 2009). Postoperative follow-up was 69 ± 33 months (range
23–119). Outcome was assessed according to Engel's classiﬁcation
(Engel 2006) by two epileptologists blinded to the imaging results
(FM, PR). Eight patients (50%) were entirely seizure free (Engel class
IA) and eight were not (Engel class not IA either continuously or at
some stage during follow-up, at least four months after surgery)
(Takahashi et al., 2012). The mean age at scan was 34 ± 9 years
(range 24–48), the mean age at seizure onset was 7 ± 8 years (range:
1–33) and the mean duration of epilepsy was 25 ± 9 years (range:12–42). All patients were diagnosed based on history, seizure semiolo-
gy, MRI, and long-term VEEG. Twelve of the sixteen patients had also
undergone SEEG, to exclude one of the following: neocortical onset
(n = 4); bilateral onset (n = 4); perisylvian onset (n = 4). Table 1
shows the clinical characteristics of the patients. Potential differences
between SF and NSF patients in age at seizure onset, duration of
epilepsy and age at operationwere assessedwithMann–WhitneyU tests.
HS was conﬁrmed on histology in 14/16 cases. As the surgical tech-
nique utilized did not use “en bloc” resections, the material available
was variable, and in two patients (#13 and #16) no ﬁrm conclusions
regarding the hippocampus could be drawn. Histology also showed ad-
ditional microdysgenesis (#3), discrete dysgenesis of the amygdala
(#4)/cystic lesion of the amygdala interpreted as ependymal canal
heterotopia (#12), small heterotopia of the temporal pole (#10, #16),
and additional chronic ischemic lesions (#15).
[11C]FMZ PET scans of forty-one control subjects (20 men and 21
women) with a mean age of 35 ± 10 years were available, obtained
on the same camera with the same protocol. They all had normal MRI
and were not treated with any regular medication.
Written informed consent had been signed by control subjects at the
time of PET scanning in agreement with the French legislation and after
approval by the local Ethics committee.
2.2. PET data acquisition
FMZ (RO15-1788) was radiolabeled with 11C using methylation
(Maziere et al., 1984). PET scans were acquired using an Exact ECAT
HR+ scanner (Siemens, Erlangen, Germany) in the high sensitivity
three-dimensional mode with a spatial resolution of about 5 mm full
with half maximum (FWHM) measured with 18F according to the
NEMAprotocol (Brix et al., 1997). For the purpose of attenuation correc-
tion, a 68Ge transmission scan was acquired.
[11C]FMZ (2.775 MBq/kg) and unlabelled FMZ (0.01 mg/kg) were
simultaneously injected (Delforge et al., 1995).
Starting at injection, dynamic three-dimensional emission images
were collected as twelve consecutive temporal frames over 55 min
and reconstructed as sixty-three contiguous slices with 2.42 mm slice
thickness and a voxel size of either 1.69 × 1.69 × 2.43 mm (data sets
acquired until 2000) or 1.72 × 1.72 × 2.43 mm (data sets acquired
from 2000), corrected for attenuation and scatter. The partial saturation
method (Delforge et al., 1995) is normally used to obtain parametric
Bmax images. However, it has recently been shown that summed [11C]
FMZ radioactivity images obtained fromdata acquired using this protocol
over the last ﬁve frames (20–55 min post-injection) are more reliable,
with regional intraclass correlation coefﬁcients approaching 0.8 on
average (Bouvard et al., 2012).
2.3. PET data analysis
[11C]FMZ summed radioactivity imageswere analyzed using statisti-
cal parametric mapping (SPM8; Wellcome Department of Imaging
Neuroscience, UCL, London, UK; http://www.ﬁl.ion.ucl.ac.uk/spm).
2.3.1. Spatial preprocessing and quality control
The images of the seven right HS patients (3/8 SF and 4/8 NSF) were
right–left reversed prior to normalization to lateralize the epileptologic
side to the left for all patients for group analyses.
As 7/16 patient data setswere right–left reversed, the same percent-
age of control data sets was reversed. The controls to be ﬂipped were
chosen at random (www.random.org). There were no substantial dif-
ferences in analysis results (activated clusters, z scores etc.) compared
to analyses with unﬂipped controls.
An in-house [11C]FMZ template in the standard Montreal Neurolog-
ical Institute (MNI) space based on thirty eight healthy subjects scanned
on the same scanner was available. Because a proportion of the raw
Table 1
Clinical data for 16 patients with refractorymTLE andHS. CBZ = Carbamazepine, CLB = Clobazam, LEV = Levetiracetam, LTG = Lamotrigine, PB = Phenobarbital, PHT = Phenytoin, PRG = Pregabaline, TPM = Topiramate, VPA = Valproic Acid.
M = male, f = female, HS = hippocampal sclerosis, CE = cluster extent, H = Hippocampus. Postoperative outcomes for non-seizure free patients are given in the footnotes, including times when the outcome class changed.
Patient Age/sex Onset/duration of
epilepsy (years)
MRI:
HS
Follow-up
(months)
Antiseizure medication at operation
*: reduced
**: stopped
(medication restarted)
Outcome
(Engel class)
[11C]FMZ-PET increases in periventricular
areas (TH = 0.01, z N 3.2, p b 0.46)
Additional information
#1 24/f 6/18 L 57 LEV, LTG* IA None Additional L temporo-occipital dysplasia on MRI
#2 22/f 2/20 L 58 CBZ, TPM, CLB** IA None Additional amygdala atrophy on MRI
#3 27/m 4/23 L 35 CBZ, VPA, CLB** IA None
#4 36/f 3/33 L 98 CBZ, LTG, TPM** IA None Additional L temporal pole signal abnormalities on
MRI; discrete dysgenesis of L amygdala on histology
#5 46/f 12/34 L 71 PB, PRG, LEV* IA None
#6 26/f 5/21 R 112 CBZ, CLB, PB*, IA R lat of ventricle z = 4.18 (42–36 8),
CE = 2.2 cm3
Additional R temporal pole signal abnormalities on MRI
#7 48/f 6/42 R 81 CBZ, CLB** IA None
#8 30/f 5/25 R 24 CBZ, TPM, CLB, LEV** IA None
#9 46/f 33/13 R 23 PHT, LEV, PB** IBa None
#10 36/f 3/33 R 116 CBZ, PB, CLB IVBb None Seizure onset right temporal and right insular on SEEG
#11 29/f 4/25 R 44 CBZ, CLB** IIAc None Small symmetric hippocampi and temporal pole
signal abnormalities on MRI; FDG PET: R mesial
temporal hypometabolism; SEEG: unilateral R onset
#12 32/m 5/27 L 119 PB, CLB** (LEV, CLB) IIAd Widespread WM increases (CE 15.3 cm3) with
the maximum L ant of frontal horn z = 6.02
(−20 34−4), but extending bilaterally with
other maxima anterior to both frontal horns
and postero-lateral of right lateral ventricle
Lateral of posterocentral portion of L lateral
ventricle z = 4.62 (−34−44 14),
CE = 3.7 cm3
Lateral of posterior portion of R lateral ventricle
z = 4.12 (30−60 12), CE = 6.5 cm3
#13 32/f 11/21 L 89 CLB, CBZ** (CBZ, PB) IIDe Lateral of anterocentral portion of R frontal horn
z = 3.27 (24 12 16), CE = 4.0 cm3
L anterior of frontal horn z = 3.82 (−18 36−4),
CE = 5.0 cm3
#14 22/m 9/13 L 72 CBZ, TPM, PB, CLB** IDf Lateral of posterocentral portion of L lateral
ventricle z = 4.51 (−34−48 16), CE = 1.7 cm3
L anterior of frontal horn z = 3.96 (−14 38−2),
CE = 1.7 cm3
#15 39/m 1/38 L 67 TPM, PB* IIAg Lateral and inferior of L ventricle where temporal
and occipital horns originate n z = 4.01
(−30−52 4), CE = 3.0 cm3
Lateral and inferior of R ventricle z = 3.29
(10 6 4), CE = 2.4 cm3
#16 41/f 3/38 R 78 LTG, CBZ, PB* ICh Lateral and inferior of R ventricle where
temporal and occipital horns originate z = 3.22
(32−48 4), CE = 1.8 cm3
Additional moderate gliosis R temporal pole on
MRI + L ventricular enlargement
a IB at 5 months and IA at 17 months.
b Never seizure free.
c IB at 5, 10, and 23 months, ID at 16 months and IA at 29 and 35 months.
d IA until 110 months.
e IA at 19 months and IID at 31 months.
f ID at 60 months.
g IIA at 67 months.
h IC at 12 and 21 months.
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245J. Yankam Njiwa et al. / NeuroImage: Clinical 3 (2013) 242–248images was left–right reversed, this template was symmetrized for
group analyses as described earlier (Didelot et al., 2010).
All images of the study were spatially normalized (Ashburner and
Friston, 1999) to this symmetric [11C]FMZ template. The normalized im-
ageswere smoothedusing an isotropicGaussian kernel of 10 mmFWHM.
For individual analyses, the original, asymmetric [11C]FMZ template
wasused, i.e. individual imageswere notﬂipped. The preprocessingwas
otherwise identical.
Differences in global values inﬂuence the global scaling procedure in
SPM and could hence in principle explain differences in low-binding
areas like the periventricular white matter. The global mean was calcu-
lated via the spm functions spm_global.m and spm_global.c in a two-
step procedure. After the computation of the mean over all voxels, the
mean of values above 1/8 of the overall mean is calculated. Global
means were compared between SF patients, NSF patients and controls
using two-tailed Student's t-tests.
2.3.2. SPM analyses
We used a combination of low-threshold relative masking and an ex-
plicitmask to include thewholewhitematter (WM) in the SPM8analysis,
as described earlier (Hammers et al., 2003b). The periventricular region
was objectively assessed with a mask constructed with basic SPM8 func-
tions as follows: The ventricles were isolated from a maximum probabil-
ity human brain atlas in MNI space (Hammers et al., 2003a). This region
was then dilated by 10 mm, to include ~10 mm tissue around the ven-
tricular system (Hammers et al., 2003a). The resulting boundaries were
regularized by smoothing the mask with a 10 × 10 × 10 mm3 (FWHM)
isotropic Gaussian kernel and thresholding at 0.25.
The statistical model included correction for global radioactivity via
a group-speciﬁc analysis of covariance (ANCOVA).
Group analyses followed by individual analyses were performed to
assess periventricular increases within the mask described above. At
the group level, the aims were to replicate our earlier ﬁnding of differ-
ences between patients with suboptimal outcome and SF patients;
and to compare both of those groups with the control group. At the in-
dividual level, each control was compared against the remaining forty
controls and each patient against all forty one controls, in order to in-
vestigate whether periventricular increases can be used at the individ-
ual level to predict postoperative outcome.
The linear contrasts used to test focal effects resulted in sets of voxel
values for each contrast which constituted parametric maps of t statistics.
The maps were thresholded at p = 0.01 uncorrected, as in our previous
study (Hammers et al., 2005). The unusually lenient initial threshold is
justiﬁed by the low number of “resolution elements” (corresponding to
independent spatial samples) in the periventricular mask (n = 55
“resels”).
We then investigated different combinations of cluster characteris-
tics in order to best differentiate between SF patients and NSF patients.
For the descriptive statistics of the clusters found in the periventricular
mask, we searched for optimum discrimination for the two parameters
“uncorrected cluster probability” and “z value of peak voxel”.
The cluster probability search space was set to 0.00–0.99 in steps of
0.01 for cluster p values. The peak voxel z score search space was any
value above 3.5 in steps of 0.5. Within this search space, all combinations
were tested for their ability to optimally discriminate SF andNSF patients.
In the present sample, the optimal conditions for distinguishing SF and
NSF patients were considering clusters in the periventricular mask fulﬁll-
ing the combined condition of a z score N3.5 for the peak voxel together
with a cluster p value ≤0.5.
3. Results
3.1. Global values
The global values of the summed radioactivity images after spatial
normalization did not differ signiﬁcantly between groups. The meanglobal values were 2202 ± 216 for SF patients, 2182 ± 303 for NSF
patients, and 2409 ± 269 for controls (pmin = 0.09).
3.2. Group analyses
3.2.1. NSF versus seizure-free patients
NSF patients had higher FMZ binding than seizure free patients
around the posterior horn of the ventricles ipsilaterally to the seizure
focus at threshold p b 0.01 (maximum z = 2.7) and contralaterally
(maximum z = 4.2). We thus replicated the ﬁndings in our previous
study (Hammers et al., 2005). In addition, in the present sample some
clusters were located around the anterior horns (see Fig. 1(c)).
There were no signiﬁcant differences between seizure free and NSF
patients for the other potential predictors for postoperative NSF out-
come, namely sex, age at seizure onset, age at surgery, and duration of
epilepsy. Results for the continuous variables are illustrated in Table 2.
3.2.2. Patient groups against controls
The group of seizure free patients had three ipsilateral clusters of in-
creased periventricular [11C]FMZ binding compared with controls (0.9,
0.45 and 0.25 cm3, maximum z = 3.31) as illustrated in Fig. 1(b).
In contrast, the group of NSF patients compared with controls had
more and larger clusters of increased periventricular [11C]FMZ binding,
with higher z scores: two ipsilateral clusters (3.0 and 2.9 cm3, maxi-
mum z = 5.25), and three contralateral clusters (3.8, 2.2 and 0.8 cm3,
maximum z = 4.33; see Fig. 1(a)).
3.3. Individual analyses
Periventricular increases in individual patients occurred in similar
regions as in the group analyses. Under the optimal threshold condi-
tions detailed in the Material and methods section, ﬁve of eight
suboptimal outcome patients (63%) showed periventricular increases
for [11C]FMZ binding when compared individually against the control
group (Table 1). One of the eight seizure free patients (13%) and one
of the 41 controls (2%) also showed periventricular [11C]FMZ increases.
When considering the presence of periventricular increases as a test
indicating NSF outcome, the test had a sensitivity of 63% (i.e. 5/8 NSF pa-
tients were correctly identiﬁed), a speciﬁcity of 88% (i.e. absence of
periventricular increases correctly predicted SF outcome in 7/8 patients),
a precision of 83% (i.e. the prediction of NSF outcome was correct in 5/6
patients with periventricular increases) and an accuracy of 75% (i.e. re-
sults were correct in 12/16 patients overall). Table 3 recapitulates the
performance of the test performed on the available data. Fig. 1(d)
illustrates areas of increased periventricular [11C]FMZ binding in an indi-
vidual NSF patient (patient #15).
4. Discussion
The association between periventricular increases of [11C]FMZ radio-
activity concentration with NSF outcome after temporal lobe resection
for HS has been conﬁrmed at the group level in an independent cohort,
using simple summed activity images.
Our previous study used methodologically more demanding
fully quantiﬁed VT images which require an arterial input function
(Hammers et al., 2005). In another previous study, VT images were
superior to both binding potential (BPND) images obtained with an
image-based input function and summed activity images for detecting
the epileptogenic abnormality in hippocampal sclerosis (Hammers
et al., 2008). An important result of the present investigation is that sim-
ple summed radioactivity images,without requirement for ametabolite-
corrected arterial plasma input function, are sufﬁcient for the purpose of
preoperatively showing periventricular increases in NSF patients after
surgery.
Other studies have shown that the complete absence of seizure
varies widely with the postoperative time (Aull-Watschinger et al.,
Fig. 1. Periventricular increases. Statistical results, visualized at p b 0.01, overlaid on the SPM8 T1-weighted template. All results are unmasked and therefore clusters outside of the
periventricularmask used for statistical assessment are also shown. Left on the image is ipsilateral to the side of surgery. Clusters with highest z-scores observedwithin the periventricular
mask are highlighted with green arrows. The notation CE stands for cluster extent. Color bar, t scores. (a) Increases in patients with suboptimal outcome (not Engel class IA), compared to
controls (zmax = 5.3 ipsilaterally (CE = 3 cm3) and zmax = 4.3 contralaterally (CE = 2.2 cm3)). (b) Patientswith Engel class IA outcome have far less important periventricular increases
compared to controls (zmax = 3.3, CE = 0.3 cm3). (c) Increases in patients not Engel IA compared to seizure-free patients; contralateral (zmax = 4.2,m CE = 0.9 cm3) and ipsilateral
(zmax = 2.7, CE = 0.56 cm3). This is the same comparison as in the cohort in Hammers et al. (2005). (d) Periventricular increases in an individual patient with suboptimal outcome,
posterior to the ipsilateral lateral ventricle (zmax = 4.0, CE = 3.0 cm3).
246 J. Yankam Njiwa et al. / NeuroImage: Clinical 3 (2013) 242–2482008; Elsharkawy et al., 2009; Kelemen et al., 2006). For example, in one
study of 153 patients withMRI-diagnosed HS sex, seizure frequency be-
fore the operation, and unilaterality of interictal EEG discharges were
used as variables in a logistic regression equation to predict outcome
after surgery (Aull-Watschinger et al., 2008). Complete seizure freedom
(Engel class IA) could not be predicted from conventional preoperative
variables.
Our hypothesis, based on the prior work cited in the introduction,
is that periventricular white matter increases of [11C]FMZ binding
indicate an increased concentration of heterotopic neurons. These
could represent a developmental abnormality, i.e. MRI-invisible
subependymal heterotopia (Hammers et al., 2003b), or be secondary
to frequent seizures. In either case, there would be dual pathologyTable 2
Evaluation of other potential predictors ofNSF = not seizure free epilepsy surgery outcome.
Predictor (median, [lower;
higher quartile])
SF patients NSF patients Mann–Whitney
U test
Age at onset (years) 5 [3.8; 6.0] 4.5 [3.0; 9.5] 32.5 (p = 0.96)
Epilepsy duration (years) 24 [20.8; 33.3] 26 [19; 34.3] 32.5 (p = 0.96)
Age at operation (years) 28.5 [25.5; 38.5] 34 [31.5; 39.5] 38.5 (p = 0.51)expected to lead to a stronger tendency for ongoing seizures after re-
moval of the main epileptogenic focus. This would reﬂect the existence
of amorewidespread epileptogenic network extendingbeyond the hip-
pocampus and beyond the limits of temporal lobectomies. Accordingly,
we used the strict criterion of non-Engel IA outcome at any time during
follow-up, similar to our previous study (Hammers et al., 2005).
Patients selected for [11C]FMZ PET hadmore complex electro-clinical
patterns than usual, which explains the rather high proportion of pa-
tients having undergone SEEG. Regions often investigated as possible al-
ternative areas of seizure onset include the insula, the posterior temporal
neocortex, the temporo–parieto-occipital junction, the supra-sylvian
operculum, and the orbito-frontal cortex. In this group, SEEG was often
used to conﬁrm mesial temporal onset or exclude an extratemporalTable 3
Test performance. SF = seizure free, NSF = not seizure free.
Clinical outcome
Test output SF NSF
SF 7 3
NSF 1 5
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ing undergone standard temporal lobectomies.
SEEG electrodes record from a diameter of atmost 10 mm. SEEG elec-
trode locations were determined clinically and did not normally include
periventricular areas which are far from the hippocampus (see Fig. 1)
and are not included in the resection volume for temporal lobectomies.
For these reasons, we cannot determine whether periventricular clusters
of increased FMZ binding show interictal epileptiform abnormalities.
In our small sample, sex did not inﬂuence the postoperative out-
come, consistent with other studies (Burneo et al., 2008; Elsharkawy
et al., 2009; Yang et al., 2011). Some studies found an effect of age at sur-
gery and epilepsy duration on postoperative outcome (Janszky et al.,
2005), while others did not (Aull-Watschinger et al., 2008; Hardy
et al., 2003; Kilpatrick et al., 1999). Again, in our small sample, there
was no signiﬁcant inﬂuence of age at seizure onset and longer duration
of epilepsy. In this context, it is remarkable that periventricular in-
creases of [11C]FMZ bindingwere once again predictive of NSF outcome,
despite the small sample size, similar to the sample size in the earlier
paper (Hammers et al., 2005).
We observed that all patients presenting periventricular increases
(6/6 patients)were takingGABA-ergic anti-epileptic drugs (AEDs) com-
paredwith 6/10 of patientswithout periventricular increases.We there-
fore checked the effect of GABA-ergic AEDs on FMZ binding. Global
values of patients presenting periventricular increases showed no sig-
niﬁcant differences compared to patients without signal increases
(p N 0.8). In addition, unlabeled FMZ was administered to all subjects
as described in the Material and methods section, therefore a similar
fraction of receptors should have been occupied.
In another study, secondarily generalized seizures and ictal dystonia
were associated with a worse two-year outcome (Janszky et al., 2005);
in this retrospective study of patients operated 5–15 years ago, we did
not have systematic data on these variables in our sample.
Aswould be expected, the prognostic value of potential predictors de-
pends on the post-operative time interval for which the assessment was
made, and there is interdependence of prognostic factors (Janszky et al.,
2005; Najm et al., 2013). For example, seizure recurrence within six
months of surgery was associated with a poor long-term postoperative
outcome (Yang et al., 2011). Among the eight patients with NSF outcome
in our study, therewere six (75%)whowere not in Engel class IA afterﬁve
years the same number as after 1.5 years. Follow-up was only non-
signiﬁcantly shorter in the SF group (5.1 ± 2.7 years) than in the NSF
group (6.3 ± 2.7 years; p b 0.39), but it cannot be excluded that even a
longer follow-up would change some of the classiﬁcations.
While the association of periventricular increases of [11C]FMZ bind-
ing and suboptimal outcome at the group level is pathophysiologically
interesting, it does not aid individual counseling. Here, we investigated
whether individualized prognosis and hence better management of
candidates for epilepsy surgery were achievable. In contrast to our ear-
lier study (Hammers et al., 2005), ﬁve of eight NSF patients and seven of
eight seizure free patients could be correctly identiﬁed using presence
or absence of periventricular increases of [11C]FMZ binding as the
criterion. The most likely explanation for this improvement is the
much larger size of the control group, with 41 controls in the present
study compared with 13 in the previous study. The importance of the
size of the control group has been noted previously (cf. (Pell et al.,
2008; Wilke et al., 2008)).
Parameters were optimized within the cohort, which was too small
for splitting into training and testing sets. There is therefore a need to
replicate the ﬁndings in other, independent cohorts.
Of note, strict application of the inclusion criteria led to the presence in
the sample of three patients (#1, 10 and 11; see Table 1) with atypical
features, whichmight by themselves indicate aworse prognosis. Interest-
ingly, two of these (and #11) overlapped with the three of the eight pa-
tients with suboptimal outcome who did not show WM periventricular
increases. This might explain the imperfect sensitivity of periventricular
[11C]FMZ binding increases, as they thus had other potential reasons fora suboptimal outcome: Patient #10 had HS but also required a partial
right insulectomy following the results of SEEG, indicating a larger seizure
onset zone than usual, and patient #11 had bilaterally small hippocampi.
In contrast, one patient (patient #6)was free of seizures after 112 months
of follow-up despite increases of [11C]FMZ binding in periventricular re-
gions, showing their imperfect speciﬁcity.
It is also important to mention that, from the clinician's perspective,
most patients in the NSF group did in fact have a very meaningful im-
provement in their seizure frequency. In addition, some of the patients
classiﬁed as NSF according to our strict criteria had identiﬁable causes
for seizure recurrence, for example due to changes in medication (pa-
tient #14, patient #15). The meaning of “NSF” in this context would
have to be explained to surgical candidates.
Our study suggests that a simpliﬁed analysis method, based on
summed [11C]FMZ radioactivity images and without the need for an ar-
terial input function, sufﬁces for predicting a higher likelihood of NSF
postoperative outcome. Nevertheless, [11C]FMZ PET is not widely avail-
able. Future work should investigate whether more widely available
PET tracers with high contrast between gray and white matter, notably
[18F]ﬂuorodeoxyglucose (FDG), can serve the same purpose. This may
also open the option of correlating SEEG results with periventricular in-
creases, which was impossible in this retrospective study as WM con-
tacts are regularly not sampled.
In summary, the association between periventricular WM increases
of [11C]FMZ binding with suboptimal outcome after temporal lobe re-
section for HS has been conﬁrmed in an independent cohort on simple
summed radioactivity images. Optimized analysis of individual patient
data suggests usefulness of [11C]FMZ-PET for individual preoperative
counseling with clinically relevant accuracy.
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